You are not currently logged in.
Access JSTOR through your library or other institution:
Factors Associated with Severe Impact of Lipodystrophy on the Quality of Life of Patients Infected with HIV-1
Jordi Blanch, Araceli Rousaud, Esteban Martínez, Elisa De Lazzari, Ana Milinkovic, Josep-Maria Peri, José-Luís Blanco, Jesús Jaen, Victor Navarro, Guillem Massana and Josep-Maria Gatell
Clinical Infectious Diseases
Vol. 38, No. 10 (May 15, 2004), pp. 1464-1470
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4529121
Page Count: 7
You can always find the topics here!Topics: HIV 1, Infections, Lipodystrophy, Side effects, Quality of life, Questionnaires, Dermatology, Injections, Highly active antiretroviral therapy, Men
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
A standardized questionnaire was used to assess the impact of lipodystrophy (LD) on quality of life (QoL). Eighty-four consecutive asymptomatic human immunodeficiency virus type 1 (HIV-1)-infected outpatients with clinical LD completed a modified version of the Dermatology Life Quality Index (DLQI) survey to measure the impact of body fat changes on their QoL. Body changes influenced dressing for 55 patients (65%), produced feelings of shame for 41 (49%), and disrupted sexual life for 23 (27%). There was a greater impact on the DLQI due to body changes among women, injection drug users, patients with abdominal or breast lipoaccumulation, and patients with a high number of non-LD side effects. Multivariate proportional odds model analysis showed that the severity of non-LD-associated side effects and the presence of breast lipoaccumulation were associated with impaired psychosocial functioning. Specific characteristics of patients, antiretroviral-based side effects, and breast lipoaccumulation exert a greater impact on QoL in HIV-1-infected patients with LD.
Clinical Infectious Diseases © 2004 Oxford University Press